Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study.

Creator(s)

Vanessa W. Stevens
Cary Thurm
Elyse M. Schwab
Matthew P. Kronman
Jeffrey S. Gerber
Samir S. Shah
Jason G. Newland, Children's Mercy Hospital
Joshua Courter
Sarah Parker
Thomas V. Brogan
Adam L. Hersh

Document Type

Article

Publication Date

3-1-2016

Identifier

PMCID: PMC4811838 DOI: 10.1007/s40121-016-0105-2

Abstract

Concomitant antibiotic use during treatment for Clostridium difficile infection (CDI) increases the risk of recurrence. Across a network of children's hospitals, 46% of patients treated for CDI received concomitant antibiotics for a median of 7 days. Concomitant antibiotic use was more common among patients with malignancies, and solid organ or bone marrow transplant. Unnecessary concomitant antibiotic use in CDI patients is a potential target for pediatric antimicrobial stewardship.

Journal Title

Infect Dis Ther

Volume

5

Issue

1

First Page

45

Last Page

51

Keywords

Clostridium difficile infection; Concomitant antibiotics; Pediatric; Children; Babies; C-diff

Recommended Citation

Stevens VW, Thurm C, Schwab EM, et al. Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study. Infect Dis Ther. 2016;5(1):45-51. doi:10.1007/s40121-016-0105-2